BACKGROUND Despite conservation strategies, shortages of O– red blood cells (RBCs)
occur. The goal of this study was to determine how utilization of O– RBCs can be reduced …

Background Blood groups and anti‐A isohemagglutinin may be involved in susceptibility to
SARS‐CoV‐2 infection. Materials and Methods We retrospectively studied 268 COVID‐19 …

Background Current evidence regarding COVID‐19 convalescent plasma (CCP) transfusion
practices is limited and heterogeneous. We aimed to determine the impact of the use of …

Background Autologous peripheral blood hematopoietic stem cell (PBSC) collection efficiency
(CE) is reportedly affected by the patient's blood properties; however, studies to identify …

… Ana Paula Hitomi Yokoyama … Ana Paula Hitomi Yokoyama … Cells were grown 48 h until
confluent then passaged with 0.25% trypsin (Sigma-Aldrich, Saint-Quentin-Fallavier, France). …

BACKGROUND Massive transfusion protocols (MTPs) provide blood products rapidly and
in fixed amounts. MTPs are commonly used in trauma but may also be used in other clinical …

Objective and design The heterogeneity of response to SARS-CoV-2 infection is directly
linked to the individual genetic background. Genetic variants of inflammasome-related genes …

Background Transfusion therapy is associated with increased morbidity, mortality and costs.
Conventional coagulation tests (CCT) are weak bleeding predictors, poorly reflecting …

INTRODUCTION COVID-19 convalescent plasma (CCP) transfusion has emerged in the
past months as an alternative approach to treat pneumonia cases of SARS-CoV-2. Current …

… APH Yokoyama designed the study, collected the information of patients, and drafted the
manuscript. JM Kutner contributed to analyzing data and revised the manuscript. AM Sakashita, …